Larry K Kvols

Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.

Raffaella Barone, Françoise Borson-Chazot, François Jamar, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.

Raffaella Barone, Françoise Borson-Chazot, François Jamar, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.

Marion de Jong, Raffaella Barone, L. Kvols, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

Giovanni Paganelli, Lisa Bodei, Stanislas Pauwels, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors.

Raffaella Barone, Stanislas Pauwels, L. Kvols, 2006, Seminars in nuclear medicine.